Newsroom

Absci 1d ago

Absci Founder and CEO Sean McClain has had a front-row seat driving the transformation of biotech. In his latest TEDx talk, Sean breaks down how the intersection of AI and biology is shifting human health and revolutionizing how science tackles disease treatment. "What if you could take the energy that goes into degeneration—think autoimmune diseases, where the body attacks itself—and flip the switch to redirect or reallocate that energy into regeneration, where the body can heal itself?" In his talk, "Can We Flip the Body's Regenerative Switch?" Sean discusses how the human body operates on a fixed energy budget, and how generative AI can design therapeutics that hold the key to redirecting that energy toward regenerative biology. 📌Watch the full TEDx talk here: https://lnkd.in/ez38WpZq

View post on LinkedIn

Absci 3d ago

We’re expanding our clinical team! Momentum is building as our AI-designed biologic ABS-201 rapidly advances in phase 1/2a clinical trials for androgenetic alopecia and endometriosis. To support this next phase, we're looking for leaders with deep expertise in clinical trial operations and drug development programs—including a background backed by advanced degree (PhD, MD, PharmD, MSc) and/or proven, hands-on leadership experience driving successful trials. Join us in shaping the future of AI-driven therapeutics. 🔬 VP of Clinical Development  🔬 Senior Clinical Trial Manager Apply today: https://lnkd.in/e-q5D6ep

View post on LinkedIn

Absci 5d ago

🎧 Listen to our latest podcast feature In a true full-circle moment, our Founder and CEO, Sean McClain, returned to the University of Arizona to sit down with his former professor, Dean John Pollard, on the university’s It's an Honor Podcast. Dr. Pollard’s Chemical Thinking course was a pivotal turning point for Sean. It was the moment he realized biology wasn't just cells or molecules, but a system: a code that could be rewritten and debugged. That spark set off a journey from a curious undergraduate, to founder and CEO of Absci—a clinical-stage biopharmaceutical advancing innovative therapeutics with generative AI. It’s an inspiring conversation on leading with curiosity, how foundational mentorships shape long-term success, and the grit it takes to transform the intersection of tech and biology. Thank you for having us, Dean Pollard and the W.A. Franke Honors College – University of Arizona team! Full episode "Generative AI and Leading with Curiosity" • Apple Podcasts: https://lnkd.in/gg_XThci • Spotify: https://lnkd.in/eKHZ3Amu

View post on LinkedIn